Assessing the Clinical Characteristics and Management of COVID-19 among Pediatric Patients in Ghana: Findings and Implications.

COVID-19 Ghana antimicrobials children guidelines hospitals outcomes

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
01 Feb 2023
Historique:
received: 20 12 2022
revised: 25 01 2023
accepted: 27 01 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 26 2 2023
Statut: epublish

Résumé

There is an increasing focus across countries on researching the management of children admitted to hospital with COVID-19. This stems from an increasing prevalence due to new variants, combined with concerns with the overuse of antimicrobials driving up resistance rates. Standard treatment guidelines (STGs) have been produced in Ghana to improve their care. Consequently, there is a need to document the clinical characteristics of children diagnosed and admitted with COVID-19 to our hospital in Ghana, factors influencing compliance to the STG and treatment outcomes. In all, 201 patients were surveyed between March 2020 and December 2021, with males accounting for 51.7% of surveyed children. Those aged between 6 and 10 years were the largest group (44.8%). Nasal congestion and fever were some of the commonest presenting complaints, while pneumonia was the commonest (80.6%) COVID-19 complication. In all, 80.0% of all admissions were discharged with no untreated complications, with a 10.9% mortality rate. A combination of azithromycin and hydroxychloroquine (41.29%) was the most prescribed antimicrobial regimen. Compliance to the STG was variable (68.2% compliance). Increased compliance was associated with a sore throat as a presenting symptom. Mortality increased following transfer to the ICU. However, current recommendations to prescribe antimicrobials without demonstrable bacterial or fungal infections needs changing to reduce future resistance. These are areas to address in the future.

Identifiants

pubmed: 36830194
pii: antibiotics12020283
doi: 10.3390/antibiotics12020283
pmc: PMC9952352
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
JAC Antimicrob Resist. 2021 Jun 14;3(2):dlab080
pubmed: 34223139
Clin Microbiol Infect. 2021 Apr;27(4):520-531
pubmed: 33418017
Int J Infect Dis. 2021 Jun;107:78-85
pubmed: 33857609
Int J Infect Dis. 2021 Mar;104:250-254
pubmed: 33434666
J Med Virol. 2021 Feb;93(2):1057-1069
pubmed: 32761898
J Antimicrob Chemother. 2017 Apr 1;72(4):1227-1234
pubmed: 27999061
Int J MCH AIDS. 2020;9(3):381-385
pubmed: 33014624
Lancet. 2021 Aug 7;398(10299):522-534
pubmed: 34273292
Lancet Glob Health. 2018 Jun;6(6):e619-e629
pubmed: 29681513
Front Pharmacol. 2020 Sep 11;11:1205
pubmed: 33071775
Pediatr Pulmonol. 2020 Oct;55(10):2565-2575
pubmed: 32725955
Pediatrics. 2022 Apr 1;149(4):
pubmed: 35322270
Expert Opin Drug Saf. 2022 Aug;21(8):1089-1111
pubmed: 35876080
Expert Rev Anti Infect Ther. 2021 Oct;19(10):1353-1366
pubmed: 33724147
BMJ. 2020 Oct 19;371:m4057
pubmed: 33077424
Antibiotics (Basel). 2022 Jun 09;11(6):
pubmed: 35740195
Cureus. 2022 Jul 25;14(7):e27230
pubmed: 35910696
Lancet Glob Health. 2020 Oct;8(10):e1264-e1272
pubmed: 32687792
Expert Rev Anti Infect Ther. 2021 Jun;19(6):805-814
pubmed: 33034234
Health Sci Rep. 2021 Dec 14;4(4):e459
pubmed: 34938900
JAC Antimicrob Resist. 2022 Oct 10;4(5):dlac102
pubmed: 36226227
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
PLoS One. 2022 Aug 1;17(8):e0272375
pubmed: 35913964
Antibiotics (Basel). 2022 Dec 15;11(12):
pubmed: 36551481
Arch Pediatr. 2021 Apr;28(3):242-248
pubmed: 33483192
BMJ. 2020 May 18;369:m1983
pubmed: 32423901
Am J Trop Med Hyg. 2020 Jun;102(6):1184-1188
pubmed: 32323646
Pediatr Pulmonol. 2021 May;56(5):837-848
pubmed: 33428826
Front Pharmacol. 2021 Jan 14;11:588106
pubmed: 33628173
J Res Pharm Pract. 2019 Oct 16;8(3):149-154
pubmed: 31728346
Pediatr Res. 2021 Mar;89(4):733-737
pubmed: 32555539
J Paediatr Child Health. 2022 Jan;58(1):39-45
pubmed: 34643307
Hosp Pract (1995). 2018 Aug;46(3):128-136
pubmed: 29652559
N Engl J Med. 2020 Nov 19;383(21):2030-2040
pubmed: 33031652
J Infect Dev Ctries. 2020 Aug 31;14(8):838-843
pubmed: 32903226
Antibiotics (Basel). 2022 Jan 14;11(1):
pubmed: 35052982
Molecules. 2020 Dec 23;26(1):
pubmed: 33374759
Int J Antimicrob Agents. 2021 Apr;57(4):106324
pubmed: 33746045
Int J Clin Pharm. 2020 Aug;42(4):1227-1236
pubmed: 32458227
Vaccines (Basel). 2022 Sep 17;10(9):
pubmed: 36146631
J Infect Public Health. 2021 May;14(5):555-560
pubmed: 33848884
Front Pediatr. 2021 Mar 18;9:625377
pubmed: 33816398
Expert Rev Anti Infect Ther. 2022 Jun;20(6):931-939
pubmed: 34591720
Balkan Med J. 2020 Aug 31;37(6):341-347
pubmed: 32865382
Infect Drug Resist. 2020 Jul 31;13:2649-2655
pubmed: 32801803
Trop Med Health. 2021 Jun 23;49(1):51
pubmed: 34162445
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468
pubmed: 32358954
Hosp Pract (1995). 2019 Apr;47(2):88-95
pubmed: 30963821
J Med Virol. 2021 Jan;93(1):234-240
pubmed: 32558955
Lancet. 2021 Dec 11;398(10317):2126-2128
pubmed: 34871545
Indian J Med Res. 2021 May&Jun;153(5&6):619-628
pubmed: 34259194
Int J Health Serv. 2022 Jan;52(1):9-22
pubmed: 33686893
BMJ. 2020 Apr 8;369:m1432
pubmed: 32269046
BMC Public Health. 2021 May 29;21(1):1015
pubmed: 34051769
Expert Rev Anti Infect Ther. 2019 Apr;17(4):285-293
pubmed: 30755077
Arch Dis Child. 2021 Feb 16;:
pubmed: 33593743
Lancet. 2020 May 30;395(10238):1678-1680
pubmed: 32401713
JAMA Pediatr. 2020 Sep 01;174(9):882-889
pubmed: 32320004
Antibiotics (Basel). 2022 Mar 25;11(4):
pubmed: 35453198
Expert Rev Anti Infect Ther. 2019 Jul;17(7):535-546
pubmed: 31257952
Lancet Reg Health Am. 2022 Feb;6:100107
pubmed: 34746913

Auteurs

Israel Abebrese Sefah (IA)

Pharmacy Practice Department, School of Pharmacy, University of Health and Allied Sciences, Ho PMB 31, Ghana.

Seth Adade Sarkodie (SA)

School of Pharmacy, University of Health and Allied Sciences, Ho PMB 31, Ghana.

Giuseppe Pichierri (G)

Microbiology Department, Torbay and South Devon NHS Foundation Trust, Lowes Bridge Torbay Hospital, Torquay TQ2 7AA, UK.

Natalie Schellack (N)

Department of Pharmacology, Faculty of Health Sciences, University of Pretoria, Pretoria 0084, South Africa.

Brian Godman (B)

Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria 0208, South Africa.
Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman 346, United Arab Emirates.

Classifications MeSH